Embracing Early Access
Compassionate use programs offer hope to patients who have ran out of options. But the benefits must be weighed against the risks.
Close log in window
If real-world data is to deliver on its promise, it needs to be standardized
The potential of blockchain to better manage RWE and access makes it an exciting prospect. However, pharma first needs to get its head aroun...
Are value-based contracts actually improving patient access to new medicines?
